In early phase development, important questions are asked and the answers required are more complex than a simple yes or no. Because a drug appears to be effective for one person doesn’t mean it will be as effective in another person. What are the range of effects and side effects? What is the optimal dosage? What are the indications and contraindications? These are difficult questions, and getting the right answers requires extraordinary skills and resources.
PAREXEL's early phase services leverage our years of experience, our deep therapeutic expertise, and our global network of facilities. All of our sites use our proprietary electronic data/product management system ClinBase™, which means that clients requiring early phase studies literally have a world of options. We can locate or co-locate studies anywhere in our Network to get the best possible mix of skills, equipment, and patient populations.
PAREXEL Early Phase is an International network of clinical units and early phase services with dedicated clinics in the following locations:
Baltimore, USA
Los Angeles, USA
Berlin, Germany
Bloemfontein, South Africa
George, South Africa
London, UK
With a comprehensive range of service offerings – including bioanalytical services, data management, biostatistics, medical writing, and pharmacokinetics – PAREXEL Early Phase is a proven partner for conducting and managing Phase I/IIa studies and programs. For more information on how best to exploit our global footprint and extraordinary expertise, please contact us at earlyphase@parexel.com.
